Found: 17
Select item for more details and to access through your institution.
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
- By:
- Publication type:
- Article
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01030-w
- By:
- Publication type:
- Article
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 355, doi. 10.1111/bjh.18432
- By:
- Publication type:
- Article
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1105, doi. 10.1111/bjh.17302
- By:
- Publication type:
- Article
A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1692, doi. 10.1177/1078155218815283
- By:
- Publication type:
- Article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
- By:
- Publication type:
- Article
Tissue factor activity is increased in neutrophils from JAK2 V617F‐mutated essential thrombocythemia and polycythemia vera patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E37, doi. 10.1002/ajh.26402
- By:
- Publication type:
- Article
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 369, doi. 10.1007/s00277-022-05056-7
- By:
- Publication type:
- Article
P-180: Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in newly diagnosed Multiple Myeloma (NDMM): analysis of vascular thrombotic events (VTEs) in the GRIFFIN study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02307-7
- By:
- Publication type:
- Article
Daratumumab + Lenalidomide, Bortezomib & Dexamethasone Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e353, doi. 10.1016/j.clml.2019.09.583
- By:
- Publication type:
- Article
Management of Relapsed and Refractory Multiple Myeloma.
- Published in:
- Journal of Clinical Outcomes Management, 2016, v. 23, n. 10, p. 470
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 3, p. 304, doi. 10.1007/s11899-021-00630-8
- By:
- Publication type:
- Article
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 20, p. 5171, doi. 10.1002/cncr.27489
- By:
- Publication type:
- Article
Evaluating Elevated Hemoglobin.
- Published in:
- 2016
- By:
- Publication type:
- Letter